Jump to content

Paroxetine

From Wikipedia
paroxetine
type of chemical entity
Subclass ofheterocyclic compound Edit
Get useMedication Edit
Stylized namePARoxetine Edit
Chemical formulaC₁₉H₂₀FNO₃ Edit
Canonical SMILESC1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4 Edit
Isomeric SMILESC1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4 Edit
Active ingredient inPaxil, Pexeva, Brisdelle Edit
World Health Organisation international non-proprietary nameparoxetine Edit
Physically dey interact plussolute carrier family 6 member 4 Edit
Route of administrationoral administration Edit
Legal status (medicine)boxed warning Edit
Pregnancy categoryAustralian pregnancy category D, US pregnancy category D Edit
Described at URLhttps://cpe.org.uk/our-news/mhra-class-2-medicines-recall-paroxetine-40mg-film-coated-tablets-crescent-pharma-limited/ Edit
Subject has roleselective serotonin reuptake inhibitor, cytochrome P-450 CYP2D6 inhibitors, second-generation antidepressive agents Edit

Paroxetine, dem sell under de brand name Paxil among odas, be an antidepressant medication of de selective serotonin reuptake inhibitor (SSRI) class[1] dem use to treat major depressive disorder, obsessive–compulsive disorder (OCD), panic disorder, social anxiety disorder, post-traumatic stress disorder (PTSD), generalized anxiety disorder, den premenstrual dysphoric disorder.[1] E sanso be used insyd de treatment of premature ejaculation,[2] den hot flashes secof menopause.[1][3] Dem dey take am orally (by mouth).[1]

Common side effects dey include drowsiness, dry mouth, loss of appetite, sweating, trouble sleeping, den sexual dysfunction.[1] Insyd sam patients, sexual dysfunction fi persist even after de drug be discontinued, a condition dem know as post-SSRI sexual dysfunction; regulatory agencies wey dey include de European Medicines Agency den Health Canada recommend say paroxetine ein product labeling warn of dis risk.[4][5] Serious side effects fi include suicidal thoughts insyd those under de age of 25, serotonin syndrome, den mania.[1]

Dem approve paroxetine for medical use insyd de United States insyd 1992 wey initially e be sold by GlaxoSmithKline.[1][6] E dey on de World Health Organization's List of Essential Medicines.[7] E be available as a generic medication.[8] Insyd 2023, na e be de 72nd most commonly prescribed medication insyd de United States, plus more dan 9 million prescriptions.[9][10] Insyd 2018, na e dey insyd de top 10 of most prescribed antidepressants insyd de United States.[11]

References

[edit | edit source]
  1. 1 2 3 4 5 6 7 "Paroxetine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 6 March 2019. Retrieved 3 March 2019.
  2. Raisi F, Soleimani R, Ahmadzadeh A, Sadati SN, Fakhrian A, Jalali MM (June 2025). "Efficacy and safety of pharmacological treatments in patients with premature ejaculation: an umbrella review of meta-analyses of randomized controlled trials". The Journal of Sexual Medicine. 22 (6): 1014–1023. doi:10.1093/jsxmed/qdaf094. PMID 40326158.
  3. Fischer A (28 June 2013). "FDA approves the first non-hormonal treatment for hot flashes associated with menopause" (Press release). Food and Drug Administration. Archived from the original on 18 January 2017.
  4. Healy D, Bahrick A, Bak M, Barbato A, Calabro RS, Chubak BM (2022). "Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin". International Journal of Risk & Safety in Medicine. 33 (1): 65–76. doi:10.3233/JRS-210023. PMC 8925105. PMID 34719438.
  5. "PRAC recommendations on signals adopted at the 13-16 May 2019 PRAC meeting" (PDF). European Medicines Agency. 11 June 2019. Retrieved 8 April 2026.
  6. Food and Drug Administration (2011). Approved Drug Products with Therapeutic Equivalence Evaluations – FDA Orange Book 31st Edition (2011): FDA Orange Book 31st Edition (2011). DrugPatentWatch.com. p. 344. ISBN 978-1-934899-81-6. Archived from the original on 6 March 2019. Retrieved 4 March 2019.
  7. World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
  8. British national formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 363. ISBN 978-0-85711-338-2.
  9. "Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
  10. "Paroxetine Drug Usage Statistics, United States, 2013 - 2023". ClinCalc. Retrieved 18 August 2025.
  11. Grohol JM (15 December 2019). "Top 25 Psychiatric Medications for 2018". psychcentral.com. Archived from the original on 25 October 2020. Retrieved 26 September 2020.
[edit | edit source]